334 related articles for article (PubMed ID: 23391620)
1. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
[TBL] [Abstract][Full Text] [Related]
2. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
4. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
Clin Exp Nephrol; 2019 Jan; 23(1):85-98. PubMed ID: 29951723
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of combined target-organ damage in patients with essential hypertension.
Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease.
Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
J Hypertens; 2009 Mar; 27(3):633-41. PubMed ID: 19262231
[TBL] [Abstract][Full Text] [Related]
8. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
Chen SC; Chang JM; Yeh SM; Su HM; Chen HC
Am J Hypertens; 2013 Feb; 26(2):243-9. PubMed ID: 23382409
[TBL] [Abstract][Full Text] [Related]
9. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
Matsumoto M; Io H; Furukawa M; Okumura K; Masuda A; Seto T; Takagi M; Sato M; Nagahama L; Omote K; Hisada A; Horikoshi S; Tomino Y
J Nephrol; 2012; 25(5):794-801. PubMed ID: 22241636
[TBL] [Abstract][Full Text] [Related]
10. Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
Shi HT; Wang XJ; Li J; Song GF; Huang ZY; Guo XY; Guo JJ; Lv ZY; Li HW; Ge JB; Cui J; Qi GM
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26553212
[TBL] [Abstract][Full Text] [Related]
11. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
Chang JM; Chen SC; Huang JC; Su HM; Chen HC
Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
[TBL] [Abstract][Full Text] [Related]
12. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
Fu X; Ren H; Xie J; Wang W; Li Y; Gao P; Chen N
JAMA Netw Open; 2022 May; 5(5):e2214460. PubMed ID: 35616936
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.
Nohara N; Io H; Matsumoto M; Furukawa M; Okumura K; Nakata J; Shimizu Y; Horikoshi S; Tomino Y
Clin Exp Nephrol; 2016 Oct; 20(5):740-747. PubMed ID: 26707759
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
15. Gender-specific association of decreased estimated glomerular filtration rate and left vertical geometry in the general population from rural Northeast China.
Dai D; Chang Y; Chen Y; Yu S; Guo X; Sun Y
BMC Cardiovasc Disord; 2017 Jan; 17(1):24. PubMed ID: 28086799
[TBL] [Abstract][Full Text] [Related]
16. Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications.
Calò LA; Vertolli U; Pagnin E; Ravarotto V; Davis PA; Lupia M; Naso E; Maiolino G; Naso A
Life Sci; 2016 Mar; 148():80-5. PubMed ID: 26872982
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors?
Masugata H; Senda S; Goda F; Yamagami A; Okuyama H; Kohno T; Hosomi N; Yukiiri K; Noma T; Imai M; Kiyomoto H; Nishiyama A; Kohno M
Clin Exp Hypertens; 2010 Jan; 32(2):113-20. PubMed ID: 20374184
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
[TBL] [Abstract][Full Text] [Related]
19. Impact of type 2 diabetes on left ventricular geometry and diastolic function in hypertensive patients with chronic kidney disease.
Nardi E; Palermo A; Mulè G; Cusimano P; Cottone S; Cerasola G
J Hum Hypertens; 2011 Mar; 25(3):144-51. PubMed ID: 20944658
[TBL] [Abstract][Full Text] [Related]
20. Impact of left ventricular remodeling and renal function on 24h-ECG recordings and cardiovascular outcome in elderly hypertensive patients.
Buonacera A; Boukhris M; Tomasello SD; Campagna A; Cilia C; Tripepi G; Di Marca S; Terranova V; Pisano M; Mastrosimone G; Galassi AR; Stancanelli B; Cataliotti A; Malatino L
Eur J Intern Med; 2016 Apr; 29():71-7. PubMed ID: 26781517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]